文献速递临床试验与 GCP流行病学与生物统计

院外心脏骤停中声门上气道装置与气管插管策略对功能结局的影响:AIRWAYS-2随机临床试验

Effect of a Strategy of a Supraglottic Airway Device vs Tracheal Intubation During Out-of-Hospital Cardiac Arrest on Functional Outcome: The AIRWAYS-2 Randomized Clinical Trial.
PubMed 文献 · JAMA · 2018-01-01

AIRWAYS-2多中心整群随机试验比较急救员初始使用声门上气道装置(SGA)与气管插管(TI)对非创伤性院外心脏骤停成人功能结局的影响。共纳入9296例患者,主要结局为出院或30天改良Rankin量表评分,SGA组良好结局6.4% vs TI组6.8%,调整风险差-0.6%(95%CI -1.6%至0.4%),两组无显著差异。SGA初始通气成功率更高(87.4% vs 79.0%),但反流和误吸无显著差异。

要点

  • SGA与TI作为初始高级气道策略在30天良好功能结局上无显著差异
  • SGA初始通气成功率显著高于TI(87.4% vs 79.0%)
  • 两组反流和误吸发生率无显著差异

核心结论

  • 在院外心脏骤停患者中,随机采用SGA策略与TI策略相比,30天功能结局无显著改善。

研究设计与样本

  • 急救员按1:1随机分配使用TI(764名)或SGA(759名)作为初始高级气道管理策略。
  • 2015年6月至2017年8月自动入组≥18岁非创伤性院外心脏骤停患者,随访至2018年2月。
  • 共纳入9296例患者(SGA组4886例,TI组4410例),中位年龄73岁,女性3373例(36.3%)。

主要发现

  • SGA组4882例中311例(6.4%)达到良好结局(mRS 0-3),TI组4407例中300例(6.8%)达到良好结局,调整风险差-0.6%(95%CI -1.6%至0.4%)。
  • SGA组4868例中4255例(87.4%)初始通气成功,TI组4397例中3473例(79.0%)初始通气成功,调整风险差8.3%(95%CI 6.3%至10.2%)。
  • TI组接受高级气道管理的比例较低:3419/4404例(77.6%),SGA组为4161/4883例(85.2%)。
  • 反流发生率SGA组1268/4865例(26.1%),TI组1072/4372例(24.5%),调整风险差1.4%(95%CI -0.6%至3.4%)。
  • 误吸发生率SGA组729/4824例(15.1%),TI组647/4337例(14.9%),调整风险差0.1%(95%CI -1.5%至1.8%)。

临床怎么用

  • 对于院外心脏骤停成人,急救员可选用SGA作为初始高级气道策略,其功能结局不劣于TI且初始通气成功率更高。
  • 选择气道策略时需考虑急救员操作熟练度及实际高级气道管理实施率。

局限性

  • 研究在英格兰急救系统开展,结果外推至其他急救体系需谨慎。
  • TI组实际接受高级气道管理的比例较低,可能影响策略效果的评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The optimal approach to airway management during out-of-hospital cardiac arrest is unknown. OBJECTIVE: To determine whether a supraglottic airway device (SGA) is superior to tracheal intubation (TI) as the initial advanced airway management strategy in adults with nontraumatic out-of-hospital cardiac arrest. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, cluster randomized clinical trial of paramedics from 4 ambulance services in England responding to emergencies for approximately 21 million people. Patients aged 18 years or older who had a nontraumatic out-of-hospital cardiac arrest and were treated by a participating paramedic were enrolled automatically under a waiver of consent between June 2015 and August 2017; follow-up ended in February 2018. INTERVENTIONS: Paramedics were randomized 1:1 to use TI (764 paramedics) or SGA (759 paramedics) as their initial advanced airway management strategy. MAIN OUTCOMES AND MEASURES: The primary outcome was modified Rankin Scale score at hospital discharge or 30 days after out-of-hospital cardiac arrest, whichever occurred sooner. Modified Rankin Scale score was divided into 2 ranges: 0-3 (good outcome) or 4-6 (poor outcome; 6 = death). Secondary outcomes included ventilation success, regurgitation, and aspiration. RESULTS: A total of 9296 patients (4886 in the SGA group and 4410 in the TI group) were enrolled (median age, 73 years; 3373 were women [36.3%]), and the modified Rankin Scale score was known for 9289 patients. In the SGA group, 311 of 4882 patients (6.4%) had a good outcome (modified Rankin Scale score range, 0-3) vs 300 of 4407 patients (6.8%) in the TI group (adjusted risk difference [RD], -0.6% [95% CI, -1.6% to 0.4%]). Initial ventilation was successful in 4255 of 4868 patients (87.4%) in the SGA group compared with 3473 of 4397 patients (79.0%) in the TI group (adjusted RD, 8.3% [95% CI, 6.3% to 10.2%]). However, patients randomized to receive TI were less likely to receive advanced airway management (3419 of 4404 patients [77.6%] vs 4161 of 4883 patients [85.2%] in the SGA group). Two of the secondary outcomes (regurgitation and aspiration) were not significantly different between groups (regurgitation: 1268 of 4865 patients [26.1%] in the SGA group vs 1072 of 4372 patients [24.5%] in the TI group; adjusted RD, 1.4% [95% CI, -0.6% to 3.4%]; aspiration: 729 of 4824 patients [15.1%] vs 647 of 4337 patients [14.9%], respectively; adjusted RD, 0.1% [95% CI, -1.5% to 1.8%]). CONCLUSIONS AND RELEVANCE: Among patients with out-of-hospital cardiac arrest, randomization to a strategy of advanced airway management with a supraglottic airway device compared with tracheal intubation did not result in a favorable functional outcome at 30 days. TRIAL REGISTRATION: ISRCTN Identifier: 08256118.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Benger JR, Kirby K, Black S, et al. Effect of a Strategy of a Supraglottic Airway Device vs Tracheal Intubation During Out-of-Hospital Cardiac Arrest on Functional Outcome: The AIRWAYS-2 Randomized Clinical Trial. JAMA. 2018. PMID: 30167701. doi:10.1001/jama.2018.11597

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。